Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2019 - 2025)

Amphastar Pharmaceuticals (AMPH) has 7 years of Amortization of Deferred Charges data on record, last reported at $866000.0 in Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 19.61% year-over-year to $866000.0; the TTM value through Dec 2025 reached $3.4 million, down 44.38%, while the annual FY2025 figure was $3.4 million, 44.38% down from the prior year.
  • Amortization of Deferred Charges reached $866000.0 in Q4 2025 per AMPH's latest filing, down from $885000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $5.2 million in Q3 2023 and bottomed at -$2.3 million in Q4 2021.
  • Average Amortization of Deferred Charges over 5 years is $1.2 million, with a median of $834000.0 recorded in 2021.
  • Peak YoY movement for Amortization of Deferred Charges: plummeted 334.58% in 2021, then soared 9610.0% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at -$2.3 million in 2021, then skyrocketed by 101.33% to $30000.0 in 2022, then skyrocketed by 9610.0% to $2.9 million in 2023, then tumbled by 75.15% to $724000.0 in 2024, then rose by 19.61% to $866000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $866000.0 in Q4 2025, $885000.0 in Q3 2025, and $842000.0 in Q2 2025.